✦ LIBER ✦

Scale-up of diagnostics for multidrug resistant tuberculosis

✍ Scribed by Maxine Caws; Dang Thi Minh Ha

Book ID: 117791597
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 444 KB
Volume: 10
Category: Article
ISSN: 1473-3099
DOI: 10.1016/s1473-3099(10)70188-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Scaling-up treatment for HIV/AIDS: lesso

Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis

✍ Rajesh Gupta; Alexander Irwin; Mario C Raviglione; Jim Yong Kim 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 86 KB

Multidrug-resistant Tuberculosis

✍ Dooley, Samuel W. 📂 Article 📅 1992 🏛 American College of Physicians 🌐 English ⚖ 521 KB

Linezolid for multidrug-resistant tuberc

Linezolid for multidrug-resistant tuberculosis

✍ Helen Cox; Nathan Ford; Jennifer Hughes; Eric Goemaere 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 38 KB

Linezolid for multidrug-resistant tuberc

Linezolid for multidrug-resistant tuberculosis

✍ Kwok-Chiu Chang; Chi-Chiu Leung; Charles L Daley 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 44 KB

Delamanid for Multidrug-Resistant Pulmon

Delamanid for Multidrug-Resistant Pulmonary Tuberculosis

✍ Gler, Maria Tarcela; Skripconoka, Vija; Sanchez-Garavito, Epifanio; Xiao, Heping 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 693 KB

Delamanid for Multidrug-Resistant Pulmon

Delamanid for Multidrug-Resistant Pulmonary Tuberculosis

✍ Gler, Maria Tarcela; Skripconoka, Vija; Sanchez-Garavito, Epifanio; Xiao, Heping 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 693 KB

## Background: Delamanid (opc-67683), a nitro-dihydro-imidazooxazole derivative, is a new antituberculosis medication that inhibits mycolic acid synthesis and has shown potent in vitro and in vivo activity against drug-resistant strains of mycobacterium tuberculosis. ## Methods: In this randomize